UCSF reports first U.S. case of male developing blood clots after Johnson & Johnson vaccination

Pool/Getty Images

By Sri Ravipati

(SAN FRANCISCO) The University of California, San Francisco on Sunday reported the first known case in the United States of an adult male developing blood clots after receiving a Johnson & Johnson COVID-19 vaccination.

The news comes after the single-shot vaccine was cleared by federal, state and local health officials over the weekend, KIPX 5 reported. The CDC halted the use of the vaccine for nearly two weeks after 15 recipients — all women under the age of 50 — developed a rare blood clot.

However, an extensive medical review and green light from the CDC on Friday, San Francisco Mayor London Breed said the city would resume its use of Johnson & Johnson’s vaccine.

California Gov. Gavin Newsom announced Saturday that the state would resume administering the J&J vaccine.

“After additional review, analysis and scrutiny, experts have concluded the Johnson & Johnson vaccine is safe, effective and will protect you against the COVID-19 virus,” Newsom said in a statement. “To date, about a million Californians have already received this vaccine – including myself and many of the state’s top doctors. I encourage all Californians to trust the science, getting vaccinated is the best way to protect ourselves and our loved ones and end the pandemic.”

Nearly 7 million doses of the J&J vaccine have been administered to date, according to the American Medical Association.

The male recipient who formed a blood clot in his leg is a Bay Area resident in his early 30s. He got the J&J vaccine on April 8 and began to experience pain in his leg and lower back on April 16. He was hospitalized and his condition is improving.

Interested in seeing San Francisco news on Twitter? Follow @SFCityBeat for stories.

Follow me to see more articles like this.

...

Follow